Epitalon/Epithalon: derived from the pineal gland, as we get older our thymus gland calcifies, and you lose melatonin and epithalon; the cells that are supposed to self-replicate decreases.
Anti-aging: slow down the aging process at a cellular level. 
Anticancer: inhibiting the development of colon cancer in rats. 
Oocyte quality: delay the aging process of oocytes by reducing reactive oxygen species and increasing mitochondrial membrane potential. 

NAD +: is widely studied for its potential to support healthy aging, cellular rejuvenation, and enhanced mitochondrial function, offering promising avenues for exploration in age-related research.

By maintaining optimal levels of NAD+, researchers can study its effects on processes such as oxidative stress, inflammation, and sirtuin activity, shedding light on critical pathways that influence overall vitality.

SS 31: mitochondria-targeting peptide known for its potent antioxidant and anti-inflammatory properties, designed to protect and repair mitochondrial function, enhancing cellular energy production and reducing oxidative stress. It is also beneficial in reducing inflammation, enhancing recovery from muscle fatigue, and promoting tissue repair, making it a powerful tool for both athletic recovery and chronic conditions.

TYPE 1: GH releasing peptides
Take 20-30 min before sleep
2 hours after food
Do not eat 30 min afterwards
5 days on 2 days off

Sermorelin: was used to treat children with short stature. Stimulates the pituitary to release Growth hormone.
Improved skin elasticity
Increased energy levels
Reduced body fat
Improved body composition
Increased strength and muscle function. Accelerated injury recovery
Improved bone health

Tesamorelin (Egrifta): This peptide can help reduce visceral fat, especially in the abdomen.  Longer acting peptide. Similar action of Sermorelin.

CJC-1295: This peptide can help boost growth hormone secretion and IGF-1 levels. The longest lasting of the peptides. A safety issue in clinical trials.

Class II GH releasing peptides: increases Gherlin (appetite)
Take 20-30 min before sleep
2 hours after food
Do not eat 30 min afterwards
5 days on 2 days off

Ipamorelin: This peptide can help increase metabolism and promote lean muscle growth. Reduces the somatostatin (the break in GH release). Does not increase cortisol or prolactin like the ones listed below.

Hexarelin - strongest GH release. It can increase prolactin levels and desensitize the receptors to endogenous growth hormone.

GHRP 2/GHRP 3/GHRP6 - increase cortisol and prolactin while decreasing receptor sensitivity

MK66 (oral version of the GHRP)- Strong appetite stimulant, may increase cortisol and prolactin.

BPC (body protective compound) 157: synthetic peptide to resemble a naturally occurring peptide in your gut to help with wound healing and repair.
-Accelerate tissue healing by increasing fibroblasts
- Angiogenesis- new capillaries / blood vessels to the injury site to help growth factors invade the injured area
Dosage: 300-500 mcg/day

Thymosin Beta 4 (TB500) - a protein that helps repair and regenerate damaged cells and tissues. Usually in combination with BPC-157. Binds to actin, which helps cells move and differentiate. Blood vessel formation reduces inflammation and apoptosis.
Reduces the number of myofibroblasts in wounds, which can reduce scarring.

An amylin agonist was first FDA-approved in 2005 as Symlin (available in 60 mcg and 120 mcg pen devices) for the treatment of both type 1 and type 2 diabetes. Due to its short half-life of approximately two hours, it required administration before every meal. Novo Nordisk has since modified the amino acid structure, resulting in the development of Cagrilintide, a next-generation amylin analog that allows for once-weekly dosing.

Cagrilintide works by suppressing glucagon secretion from pancreatic alpha cells, thereby lowering blood glucose levels. It also promotes enhanced satiety and significantly reduces food noise—effects that may surpass those seen with GLP-1/GIP receptor agonists.

This makes Cagrilintide an excellent complementary option to current weight loss peptides for individuals seeking greater appetite control and improved glycemic regulation.

***See weight loss services for more FDA approved options

AOD 9604: This peptide mimics the fat-burning activity of HGH, promoting the breakdown of fat cells (lipolysis) and inhibiting the formation of new fat tissue (lipogenesis). Unlike HGH, AOD 9604 does not affect blood sugar levels or cause cartilage or bone growth, which may reduce the risk of side effects and make it more targeted in its action. It has also been explored for its potential anti-inflammatory and regenerative properties, including enhancing cartilage repair and supporting joint health, making it relevant for individuals with osteoarthritis or sports-related injuries

MOTS-C: is a mitochondrial-derived peptide that plays a key role in regulating metabolic function, enhancing fat metabolism, and improving energy levels by optimizing mitochondrial efficiency.

This peptide helps improve insulin sensitivity, making it beneficial for individuals looking to optimize glucose utilization and support healthy blood sugar levels. Beyond metabolic benefits, MOTS-c may also offer anti-aging effects, protection against age-related diseases, and improved exercise capacity and endurance.

Kisspeptin: may be a treatment for infertility by regulating GNRH buy regulating LH and FSH. which stimulate the production of testosterone and estrogen. This peptide plays a pivotal role in stimulating the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), making it essential for fertility and reproductive health research.

Studies have shown Kisspeptin's potential to influence mood, behavior, and stress regulation, highlighting its broader implications for neuroendocrine and emotional well-being.

In addition to its reproductive benefits, Kisspeptin has been explored for its potential in enhancing metabolic function and maintaining healthy weight levels in various models.

PT-141 (Bremelanotide) targets the nervous system directly, stimulating neural pathways that heighten sexual desire providing people with low libido and sexual dysfunction an option to enjoy sex again.

The FDA approved Vyleesi (bremelanotide injection at 1.75 mg/0.3 ml subQ) for women with hypoactive sexual desire disorder (HSDD in July of 2019.

This peptide has demonstrated effectiveness in addressing erectile dysfunction (ED) in men and arousal disorders in women, serving as a non-hormonal option for improving sexual function.

Beyond its primary role, PT-141 may also support mood enhancement and stress reduction, promoting emotional balance and well-being.